Healthcare provider profile · identity verified

Ditte Gail Phillips, MD

Internal Medicine · CLYDE, NC · NPI 1720072101

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	567	136
Amlodipine Besylate	Amlodipine Besylate	468	123
Rosuvastatin Calcium	Rosuvastatin Calcium	398	116
Lisinopril	Lisinopril	395	107
Losartan Potassium	Losartan Potassium	380	108
Omeprazole	Omeprazole	376	100
Atorvastatin Calcium	Atorvastatin Calcium	372	101
Simvastatin	Simvastatin	264	75
Hydrochlorothiazide	Hydrochlorothiazide	241	70
Gabapentin	Gabapentin	233	61
Meloxicam	Meloxicam	224	56
Pantoprazole Sodium	Pantoprazole Sodium	188	48
Alendronate Sodium	Alendronate Sodium	179	44
Metoprolol Succinate	Metoprolol Succinate	178	58
Metformin Hcl Er	Metformin Hcl	164	47
Trazodone Hcl	Trazodone Hcl	162	44
Metformin Hcl	Metformin Hcl	155	46
Tramadol Hcl	Tramadol Hcl	150	32
Pravastatin Sodium	Pravastatin Sodium	143	46
Sertraline Hcl	Sertraline Hcl	143	33
Alprazolam	Alprazolam	124	24
Eliquis	Apixaban	122	23
Furosemide	Furosemide	107	33
Ozempic	Semaglutide	107	16
Escitalopram Oxalate	Escitalopram Oxalate	103	31
Potassium Chloride	Potassium Chloride	102	29
Metoprolol Tartrate	Metoprolol Tartrate	97	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	22
Citalopram Hbr	Citalopram Hydrobromide	86	26
Duloxetine Hcl	Duloxetine Hcl	85	19
Albuterol Sulfate Hfa	Albuterol Sulfate	84	36
Irbesartan	Irbesartan	84	25
Famotidine	Famotidine	82	23
Clonazepam	Clonazepam	78	15
Allopurinol	Allopurinol	77	22
Synthroid	Levothyroxine Sodium	77	19
Zolpidem Tartrate	Zolpidem Tartrate	77	18
Fluticasone Propionate	Fluticasone Propionate	72	30
Buspirone Hcl	Buspirone Hcl	71	20
Glipizide Er	Glipizide	70	15
Tamsulosin Hcl	Tamsulosin Hcl	67	22
Atenolol	Atenolol	66	16
Montelukast Sodium	Montelukast Sodium	66	19
Carvedilol	Carvedilol	65	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	23
Lorazepam	Lorazepam	62	12
Mirtazapine	Mirtazapine	62	14
Oxybutynin Chloride Er	Oxybutynin Chloride	57	15
Warfarin Sodium	Warfarin Sodium	57	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	15
Celecoxib	Celecoxib	47	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	11
Clopidogrel	Clopidogrel Bisulfate	45	12
Valsartan	Valsartan	44	12
Trulicity	Dulaglutide	43	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	13
Bupropion Xl	Bupropion Hcl	41	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Xarelto	Rivaroxaban	36	suppressed
Fenofibrate	Fenofibrate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Spironolactone	Spironolactone	34	11
Glimepiride	Glimepiride	32	suppressed
Glipizide	Glipizide	32	suppressed
Temazepam	Temazepam	32	suppressed
Prednisone	Prednisone	30	15
Chlorthalidone	Chlorthalidone	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	25
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Diazepam	Diazepam	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Nystatin	Nystatin	25	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	20
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	20	11
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Fluconazole	Fluconazole	19	14
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Estradiol	Estradiol	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Azithromycin	Azithromycin	16	15
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	11
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Finasteride	Finasteride	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Colchicine	Colchicine	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error